MTOR and neoplasm: Mechanistically, the metabolic shift induced by KD inhibits oncogenic pathways such as PI3K/Akt/mTOR and Ras/Raf/MEK/ERK, while simultaneously activating AMPK, reinforcing mTOR inhibition and enhancing metabolic stress in tumor cells.